FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1521961000168108: Kabiven G19% (alanine 7.2 g / 1.54 L + arginine 5.1 g / 1.54 L + aspartic acid 1.5 g / 1.54 L + calcium chloride dihydrate 440 mg / 1.54 L + glutamic acid 2.5 g / 1.54 L + glycine 3.6 g / 1.54 L + histidine 3.1 g / 1.54 L + isoleucine 2.5 g / 1.54 L + leucine 3.6 g / 1.54 L + lysine hydrochloride 5.1 g / 1.54 L + magnesium sulfate heptahydrate 1.5 g / 1.54 L + methionine 2.5 g / 1.54 L + phenylalanine 3.6 g / 1.54 L + potassium chloride 2.7 g / 1.54 L + proline 3.1 g / 1.54 L + serine 2 g / 1.54 L + sodium acetate trihydrate 3.7 g / 1.54 L + sodium glycerophosphate 2.3 g / 1.54 L + threonine 2.5 g / 1.54 L + tryptophan 860 mg / 1.54 L + tyrosine 100 mg / 1.54 L + valine 3.3 g / 1.54 L) injection [1 x 450 mL chamber] (&) (glucose 150 g / 1.54 L) injection [1 x 790 mL chamber] (&) (soya oil 60 g / 1.54 L) injection [1 x 300 mL chamber], 4 x 1.54 L multi-chamber bags (trade product pack)

Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4517241000168110 Kabiven G19% (alanine 7.2 g / 1.54 L + arginine 5.1 g / 1.54 L + aspartic acid 1.5 g / 1.54 L + calcium chloride dihydrate 440 mg / 1.54 L + glutamic acid 2.5 g / 1.54 L + glycine 3.6 g / 1.54 L + histidine 3.1 g / 1.54 L + isoleucine 2.5 g / 1.54 L + leucine 3.6 g / 1.54 L + lysine hydrochloride 5.1 g / 1.54 L + magnesium sulfate heptahydrate 1.5 g / 1.54 L + methionine 2.5 g / 1.54 L + phenylalanine 3.6 g / 1.54 L + potassium chloride 2.7 g / 1.54 L + proline 3.1 g / 1.54 L + serine 2 g / 1.54 L + sodium acetate trihydrate 3.7 g / 1.54 L + sodium glycerophosphate 2.3 g / 1.54 L + threonine 2.5 g / 1.54 L + tryptophan 860 mg / 1.54 L + tyrosine 100 mg / 1.54 L + valine 3.3 g / 1.54 L) injection [1 x 450 mL chamber] (&) (glucose 150 g / 1.54 L) injection [1 x 790 mL chamber] (&) (soya oil 60 g / 1.54 L) injection [1 x 300 mL chamber], 4 x 1.54 L multi-chamber bags (trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4517251000168112 Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags Is a glucose 150 g/1.54 L injection [790 mL chamber] (&) alanine 7.2 g/1.54 L + arginine 5.1 g/1.54 L + aspartic acid 1.5 g/1.54 L + glutamic acid 2.5 g/1.54 L + glycine 3.6 g/1.54 L + histidine 3.1 g/1.54 L + isoleucine 2.5 g/1.54 L + leucine 3.6 g/1.54 L + lysine hydrochloride 5.1 g/1.54 L + methionine 2.5 g/1.54 L + phenylalanine 3.6 g/1.54 L + proline 3.1 g/1.54 L + serine 2 g/1.54 L + threonine 2.5 g/1.54 L + tryptophan 860 mg/1.54 L + tyrosine 100 mg/1.54 L + valine 3.3 g/1.54 L + calcium chloride dihydrate 440 mg/1.54 L + sodium glycerophosphate 2.3 g/1.54 L + magnesium sulfate heptahydrate 1.5 g/1.54 L + potassium chloride 2.7 g (potassium 36 mmol)/1.54 L + sodium acetate trihydrate 3.7 g/1.54 L injection [450 mL chamber] (&) soya oil 60 g/1.54 L injection [300 mL chamber], 4 x 1.54 L multi-chamber bags true Inferred relationship Some
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags Is a trade product pack true Inferred relationship Some
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags has TP Kabiven G19% true Inferred relationship Some
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags has TPUU Kabiven G19% Glucose 150 g/1.54 L injection, 790 mL chamber true Inferred relationship Some 235231935
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags has TPUU Kabiven G19% Intralipid 60 g/1.54 L injection, 300 mL chamber true Inferred relationship Some 958376726
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags has TPUU Kabiven G19% Vamin 18 Novum injection, 450 mL chamber true Inferred relationship Some 1374771065
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags has subpack glucose 150 g/1.54 L injection [790 mL chamber] (&) alanine 7.2 g/1.54 L + arginine 5.1 g/1.54 L + aspartic acid 1.5 g/1.54 L + glutamic acid 2.5 g/1.54 L + glycine 3.6 g/1.54 L + histidine 3.1 g/1.54 L + isoleucine 2.5 g/1.54 L + leucine 3.6 g/1.54 L + lysine hydrochloride 5.1 g/1.54 L + methionine 2.5 g/1.54 L + phenylalanine 3.6 g/1.54 L + proline 3.1 g/1.54 L + serine 2 g/1.54 L + threonine 2.5 g/1.54 L + tryptophan 860 mg/1.54 L + tyrosine 100 mg/1.54 L + valine 3.3 g/1.54 L + calcium chloride dihydrate 440 mg/1.54 L + sodium glycerophosphate 2.3 g/1.54 L + magnesium sulfate heptahydrate 1.5 g/1.54 L + potassium chloride 2.7 g (potassium 36 mmol)/1.54 L + sodium acetate trihydrate 3.7 g/1.54 L injection [450 mL chamber] (&) soya oil 60 g/1.54 L injection [300 mL chamber], 1.54 L multi-chamber bag true Inferred relationship Some 1884959585
Inbound Relationships Type Active Source Characteristic Refinability Group
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags Is a True Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags Inferred relationship Some

Reference Sets

Trade product pack reference set

Back to Start